$MRIN
MARIN SOFTWARE INC

2024 Q4 Form 10-Q Financial Statement

#000095017024125387 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $4.282M $4.438M
YoY Change -3.52% -10.83%
Cost Of Revenue $1.703M $3.087M
YoY Change -44.83% -2.96%
Gross Profit $2.579M $1.351M
YoY Change 90.9% -24.78%
Gross Profit Margin 60.23% 30.44%
Selling, General & Admin $2.951M $3.601M
YoY Change -18.05% -21.43%
% of Gross Profit 114.42% 266.54%
Research & Development $1.760M $2.860M
YoY Change -38.46% -5.74%
% of Gross Profit 68.24% 211.7%
Depreciation & Amortization $1.000K $440.0K
YoY Change -99.77% -7.56%
% of Gross Profit 0.04% 32.57%
Operating Expenses $4.711M $6.461M
YoY Change -27.09% -15.18%
Operating Profit -$2.132M -$5.110M
YoY Change -58.28% -12.21%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$176.0K $158.0K
YoY Change -211.39% -16.84%
Pretax Income -$2.308M -$4.952M
YoY Change -53.39% -12.06%
Income Tax $18.00K $2.000K
% Of Pretax Income
Net Earnings -$2.326M -$4.954M
YoY Change -53.05% -13.63%
Net Earnings / Revenue -54.32% -111.63%
Basic Earnings Per Share -$0.74 -$0.28
Diluted Earnings Per Share -$0.74 -$0.28
COMMON SHARES
Basic Shares Outstanding 3.143M 3.129M 17.79M
Diluted Shares Outstanding 3.135M 17.91M

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.588M $13.60M
YoY Change -58.91% -56.79%
Cash & Equivalents $5.588M $13.60M
Short-Term Investments
Other Short-Term Assets $1.479M $1.400M
YoY Change 5.64% -38.24%
Inventory
Prepaid Expenses
Receivables $3.661M $4.026M
Other Receivables $0.00 $0.00
Total Short-Term Assets $10.73M $19.06M
YoY Change -43.71% -49.82%
LONG-TERM ASSETS
Property, Plant & Equipment $934.0K $3.514M
YoY Change -73.42% 9.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $518.0K $486.0K
YoY Change 6.58% -16.64%
Total Long-Term Assets $1.452M $6.278M
YoY Change -76.87% -21.8%
TOTAL ASSETS
Total Short-Term Assets $10.73M $19.06M
Total Long-Term Assets $1.452M $6.278M
Total Assets $12.18M $25.34M
YoY Change -51.93% -44.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $579.0K $1.035M
YoY Change -44.06% 45.77%
Accrued Expenses $2.908M $414.0K
YoY Change 602.42% -56.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.487M $5.049M
YoY Change -30.94% -26.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.015M $989.0K
YoY Change 2.63% 4.44%
Total Long-Term Liabilities $1.015M $989.0K
YoY Change 2.63% 4.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.487M $5.049M
Total Long-Term Liabilities $1.015M $989.0K
Total Liabilities $4.502M $6.820M
YoY Change -33.99% -34.87%
SHAREHOLDERS EQUITY
Retained Earnings -$351.0M -$339.0M
YoY Change 3.55% 6.86%
Common Stock $359.7M $358.5M
YoY Change 0.35% 1.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.678M $18.52M
YoY Change
Total Liabilities & Shareholders Equity $12.18M $25.34M
YoY Change -51.93% -44.93%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$2.326M -$4.954M
YoY Change -53.05% -13.63%
Depreciation, Depletion And Amortization $1.000K $440.0K
YoY Change -99.77% -7.56%
Cash From Operating Activities -$2.341M -$4.890M
YoY Change -52.13% -2.12%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $350.0K
YoY Change -100.0% -177.26%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$350.0K
YoY Change -100.0% -22.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -19.00K -110.0K
YoY Change -82.73% -60.85%
NET CHANGE
Cash From Operating Activities -2.341M -4.890M
Cash From Investing Activities 0.000 -350.0K
Cash From Financing Activities -19.00K -110.0K
Net Change In Cash -2.360M -5.350M
YoY Change -55.89% -6.63%
FREE CASH FLOW
Cash From Operating Activities -$2.341M -$4.890M
Capital Expenditures $0.00 $350.0K
Free Cash Flow -$2.341M -$5.240M
YoY Change -55.32% 15.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001389002
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35838
dei Entity Registrant Name
EntityRegistrantName
Marin Software Incorporated
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4647180
dei Entity Address Address Line1
EntityAddressAddressLine1
149 New Montgomery Street
dei Entity Address Address Line2
EntityAddressAddressLine2
4th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94105
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
399-2580
dei Security12b Title
Security12bTitle
Common Stock, $0.001 Par Value Per Share
dei Trading Symbol
TradingSymbol
MRIN
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3143449
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5588000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11363000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3661000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3864000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1479000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1548000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
10728000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
16775000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
115000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
120000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
819000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1912000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
518000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
508000
CY2024Q3 us-gaap Assets
Assets
12180000
CY2023Q4 us-gaap Assets
Assets
19315000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
579000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
664000
CY2024Q3 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2089000
CY2023Q4 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2099000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
819000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1518000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3487000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4281000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
394000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1015000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1001000
CY2024Q3 us-gaap Liabilities
Liabilities
4502000
CY2023Q4 us-gaap Liabilities
Liabilities
5676000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
47619000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
47619000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3143000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3143000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3011000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3011000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
3000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
359718000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
358884000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-351006000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-344251000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1037000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-997000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
7678000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
13639000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12180000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19315000
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4282000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4438000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12358000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13381000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
1703000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
3087000
us-gaap Cost Of Revenue
CostOfRevenue
5136000
us-gaap Cost Of Revenue
CostOfRevenue
9501000
CY2024Q3 us-gaap Gross Profit
GrossProfit
2579000
CY2023Q3 us-gaap Gross Profit
GrossProfit
1351000
us-gaap Gross Profit
GrossProfit
7222000
us-gaap Gross Profit
GrossProfit
3880000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1091000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1482000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3384000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5442000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1760000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2860000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5440000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8599000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1860000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2119000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5144000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6897000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
4711000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
6461000
us-gaap Operating Expenses
OperatingExpenses
13968000
us-gaap Operating Expenses
OperatingExpenses
20938000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2132000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5110000
us-gaap Operating Income Loss
OperatingIncomeLoss
-6746000
us-gaap Operating Income Loss
OperatingIncomeLoss
-17058000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-176000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
158000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
66000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
598000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2308000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4952000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6680000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16460000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
75000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
194000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2326000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4954000
us-gaap Net Income Loss
NetIncomeLoss
-6755000
us-gaap Net Income Loss
NetIncomeLoss
-16654000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-45000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
25000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-40000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2371000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4929000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6795000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16653000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.7
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.7
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3135000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3135000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2985000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2985000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3089000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3089000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2920000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2920000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
9859000
CY2024Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
23000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
213000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2326000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-45000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
7678000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
23254000
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
126000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
319000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4954000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
25000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
18518000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
13639000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
123000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
957000
us-gaap Net Income Loss
NetIncomeLoss
-6755000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-40000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
7678000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
32714000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
231000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2681000
us-gaap Net Income Loss
NetIncomeLoss
-16654000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
18518000
us-gaap Profit Loss
ProfitLoss
-6755000
us-gaap Profit Loss
ProfitLoss
-16654000
us-gaap Depreciation
Depreciation
5000
us-gaap Depreciation
Depreciation
17000
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
0
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1278000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1165000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1162000
mrin Amortization Of Deferred Costs To Obtain And Fulfill Contracts
AmortizationOfDeferredCostsToObtainAndFulfillContracts
267000
mrin Amortization Of Deferred Costs To Obtain And Fulfill Contracts
AmortizationOfDeferredCostsToObtainAndFulfillContracts
277000
mrin Gain Loss On Disposals Of Property And Equipment And Right Of Use Asset
GainLossOnDisposalsOfPropertyAndEquipmentAndRightOfUseAsset
0
mrin Gain Loss On Disposals Of Property And Equipment And Right Of Use Asset
GainLossOnDisposalsOfPropertyAndEquipmentAndRightOfUseAsset
-2000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-199000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-43000
us-gaap Share Based Compensation
ShareBasedCompensation
957000
us-gaap Share Based Compensation
ShareBasedCompensation
2594000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-7000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-388000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-3000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-113000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-872000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
235000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-345000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-102000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
21000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-85000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1041000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1165000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1162000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5646000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12634000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
0
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1511000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1511000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
116000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
199000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
-3000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-116000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-202000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-13000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-13000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5775000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14360000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11363000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27957000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5588000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13597000
mrin Reverse Stock Split And Reduction In Authorized Shares Policytext Block
ReverseStockSplitAndReductionInAuthorizedSharesPolicytextBlock
<p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reverse Stock Split and Reduction in Authorized Shares</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 12, 2024, the Company effected a reverse stock split of its outstanding common stock and a reduction in the Company's authorized shares of common stock. As a result of the reverse stock split, each six outstanding shares of the Company’s common stock were combined into one outstanding share of common stock, without any change in par value. The common stock began trading on the Nasdaq Capital Market on a split-adjusted basis on April 15, 2024. No fractional shares were issued in connection with the reverse stock split as the Company paid the fair value of such fractional shares in cash. As a result of the reduction in the Company's authorized shares of common stock, the Company's authorized shares went from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">142,857</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">47,619</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All share and per share amounts of the Company’s common stock, as well as stock options and restricted stock units (“RSUs”), included in the accompanying condensed consolidated financial statements have been retroactively adjusted to give effect to the reverse stock split for all periods presented, unless indicated otherwise. In addition, as a result of the reverse stock split, the Company reclassified an amount equal to the reduction in the par value of common stock to additional paid-in capital on its condensed consolidated balance sheets.</span></p>
us-gaap Net Income Loss
NetIncomeLoss
-6755000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
21917000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5588000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-351006000
us-gaap Restructuring And Related Activities Description
RestructuringAndRelatedActivitiesDescription
The 2023 Restructuring Plan resulted in the reduction of the Company's global employees by 64 full-time employees during the second half of 2023, reducing its total headcount by approximately 37%. The 2023 Restructuring Plan was substantially complete in 2023
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
501000
mrin Provision For Doubtful Accounts Reductions To Expense
ProvisionForDoubtfulAccountsReductionsToExpense
7000
mrin Allowance For Doubtful Accounts Receivable Write Offs And Other Deductions
AllowanceForDoubtfulAccountsReceivableWriteOffsAndOtherDeductions
74000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
420000
CY2024Q3 mrin Allowance For Potential Customer Revenue Credits
AllowanceForPotentialCustomerRevenueCredits
17000
CY2023Q4 mrin Allowance For Potential Customer Revenue Credits
AllowanceForPotentialCustomerRevenueCredits
12000
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
0
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
0
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
0
mrin Company Capitalized
CompanyCapitalized
1511000
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1278000
mrin Subscription Contracts Term
SubscriptionContractsTerm
P1Y
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
171000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
401000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
572000
mrin Unsatisfied Performance Obligation On Subscription Contract Term
UnsatisfiedPerformanceObligationOnSubscriptionContractTerm
P1Y
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4282000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4438000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12358000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13381000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4282000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4438000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12358000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13381000
mrin Deferred Costs To Fulfill Contracts Expected Period Of Benefit
DeferredCostsToFulfillContractsExpectedPeriodOfBenefit
P30M
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2024Q3 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2023Q3 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53652000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53658000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
50261000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
50262000
CY2024Q3 mrin Accumulated Impairment Losse
AccumulatedImpairmentLosse
3276000
CY2023Q4 mrin Accumulated Impairment Losse
AccumulatedImpairmentLosse
3276000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
115000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
120000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
436000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1295000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
862000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
872000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
481000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
376000
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
227000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
192000
CY2024Q3 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
506000
CY2023Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
636000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
23000
CY2024Q3 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2089000
CY2023Q4 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2099000
CY2023 mrin Wrote Off Credit Balance
WroteOffCreditBalance
443000
CY2023Q3 mrin Wrote Off Credit Balance
WroteOffCreditBalance
43000
mrin Wrote Off Credit Balance
WroteOffCreditBalance
443000
CY2024Q3 mrin Wrote Off Credit Balance
WroteOffCreditBalance
0
mrin Wrote Off Credit Balance
WroteOffCreditBalance
0
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
213000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
309000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
957000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2594000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y6M
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
429000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1284000
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
439000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1403000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
414000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
414000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
828000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
9000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
819000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
819000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
us-gaap Operating Lease Payments
OperatingLeasePayments
1284000
us-gaap Operating Lease Payments
OperatingLeasePayments
1403000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
72000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
161000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
75000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2308000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6680000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
194000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4952000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16460000
CY2024Q3 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
374000
CY2024Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2023Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2326000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4954000
us-gaap Net Income Loss
NetIncomeLoss
-6755000
us-gaap Net Income Loss
NetIncomeLoss
-16654000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3135000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3135000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2985000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2985000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3089000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3089000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2920000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2920000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.7
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.7
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
145000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
355000

Files In Submission

Name View Source Status
0000950170-24-125387-index-headers.html Edgar Link pending
0000950170-24-125387-index.html Edgar Link pending
0000950170-24-125387.txt Edgar Link pending
0000950170-24-125387-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mrin-20240930.htm Edgar Link pending
mrin-20240930.xsd Edgar Link pending
mrin-ex31_1.htm Edgar Link pending
mrin-ex31_2.htm Edgar Link pending
mrin-ex32_1.htm Edgar Link pending
mrin-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
mrin-20240930_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable